Sylvie Beljanski shares how plant extracts may target cancer cells, support prostate cancer care, and enhance treatment outcomes.

Sylvie Beljanski explores the science behind plant-based compounds that may selectively target cancer cells while sparing healthy tissue. She discusses research on prostate cancer, advanced cancer models, and cancer stem cells, along with the potential synergy between natural extracts and chemotherapy. The conversation highlights the importance of integrative approaches and ongoing scientific validation in cancer care.

Sylvie Beljanski, a French lawyer turned health advocate, author, and entrepreneur, is dedicated to continuing the Beljanski family legacy as international leaders in health and cancer research.

She is the Founder and President of The Beljanski Foundation, a 501(c)(3) nonprofit focusing on natural approaches to cancer, and serves as CEO of Maison Beljanski, an international dietary supplement company.

Sylvie is also the producer of the Beljanski Integrative Cancer Conference, a premier event bringing together leading experts and advocates in integrative medicine to advance natural approaches to cancer care. Her passion for holistic health and integrative medicine has made her a sought-after speaker at global health conferences, where she has educated thousands about scientific breakthroughs in these fields.